1. Home
  2. BOLD vs NVNI Comparison

BOLD vs NVNI Comparison

Compare BOLD & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • NVNI
  • Stock Information
  • Founded
  • BOLD 2018
  • NVNI 2019
  • Country
  • BOLD United States
  • NVNI Brazil
  • Employees
  • BOLD N/A
  • NVNI N/A
  • Industry
  • BOLD
  • NVNI
  • Sector
  • BOLD
  • NVNI
  • Exchange
  • BOLD Nasdaq
  • NVNI Nasdaq
  • Market Cap
  • BOLD 24.4M
  • NVNI 31.5M
  • IPO Year
  • BOLD 2024
  • NVNI N/A
  • Fundamental
  • Price
  • BOLD $1.12
  • NVNI $0.37
  • Analyst Decision
  • BOLD Buy
  • NVNI
  • Analyst Count
  • BOLD 3
  • NVNI 0
  • Target Price
  • BOLD $4.00
  • NVNI N/A
  • AVG Volume (30 Days)
  • BOLD 279.9K
  • NVNI 1.2M
  • Earning Date
  • BOLD 08-11-2025
  • NVNI 08-07-2025
  • Dividend Yield
  • BOLD N/A
  • NVNI N/A
  • EPS Growth
  • BOLD N/A
  • NVNI N/A
  • EPS
  • BOLD N/A
  • NVNI N/A
  • Revenue
  • BOLD N/A
  • NVNI $31,250,627.00
  • Revenue This Year
  • BOLD N/A
  • NVNI $12.05
  • Revenue Next Year
  • BOLD N/A
  • NVNI $15.02
  • P/E Ratio
  • BOLD N/A
  • NVNI N/A
  • Revenue Growth
  • BOLD N/A
  • NVNI 1491.58
  • 52 Week Low
  • BOLD $1.00
  • NVNI $0.14
  • 52 Week High
  • BOLD $4.72
  • NVNI $12.19
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • NVNI 54.74
  • Support Level
  • BOLD N/A
  • NVNI $0.31
  • Resistance Level
  • BOLD N/A
  • NVNI $0.36
  • Average True Range (ATR)
  • BOLD 0.00
  • NVNI 0.03
  • MACD
  • BOLD 0.00
  • NVNI 0.01
  • Stochastic Oscillator
  • BOLD 0.00
  • NVNI 80.84

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

Share on Social Networks: